Precision Optics Corporation, Inc. (POCI)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $4.33
- As of
Kresmion compiles this page from POCI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PRECISION OPTICS CORPORATION, INC. (POCI): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-K filed 2026-09-28.
See the full POCI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for POCI on one page. Preview it with sample data, then open it live with a free account.
Preview the POCI dossierActive signals for POCI
- mediumEarnings above estimates
Q4-2026: Beat consensus by 83.7%, EPS $-0.01 vs $-0.0612 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +89% to POCI (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in POCI
FREE, NO ACCOUNT
Every signal on POCI, as it fires
New filings, 13F moves and cross asset signals on POCI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in POCI (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 740294400 · 2026Q2 | $276K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 740294400 · 2026Q2 | $213K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, POCI
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
POCI against its peers
POCI's operating margin of -11.1% ranks in the 50th percentile of 18 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | POCI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 31.5M USD | 35.3M USD | 45 | 18 |
| Revenue YoY | 65.2% | n/a | n/a | 4 |
| Gross margin | 17.2% | 57.4% | 13 | 18 |
| Operating margin | -11.1% | -31.3% | 50 | 18 |
| Net margin | -11.5% | -36.4% | 57 | 19 |
| Return on equity | -17.8% | -39.8% | 55 | 20 |
Peers (22): NEPH, HBIO, MBOT, MLSS, STXS, NYXH, RVP, NNNN, KRMD, BNGO, ZJYL, FEMY, UEEC, CUPR, PDEX, RGNT, UTMD, OSUR, SMTI, LUCY, EMBC, MHUAF. Left out: DXR (no annual filing), ZTEKF (no annual filing), DAVI (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (POCI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow POCI on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to POCI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.